Patent · US Active

Avian influenza chimeric VLPS

US8551756B2 · kind B2 · utility

17Cited by

2References

15Claims

0Family size

Assignee

Novavax, Inc. · US

Inventors

Gale Smith · Germantown, US
Peter Pushko · Frederick, US

Key dates

Filing date	Jan 19, 2010
Grant date	Oct 8, 2013
Priority date	—
Expiry date	Jul 23, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.